Details of the Drug Reposition

General Information of This Drug (ID: DMGOLCU)

Drug Name
MV-NIS   DMGOLCU
Synonyms
MV-NIS (intratumoral, SCCHN); Measles virus encoding thyroidal sodium iodide symporter (intratumoral, Head and neck tumor), Nisco International Inc; MV-NIS (intratumoral, SCCHN), Nisco International Inc
Drug Type
Oncolytic virus therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 2 [1]
Head and neck cancer DISBPSQZ 2D42 Phase 2 [2]
------------------------------------------------------------------------------------
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Medulloblastoma DISZD2ZL 2A00.10 Phase 1 [1]
Urothelial carcinoma DISRTNTN 2C92.0 Phase 1 [3]
Bladder cancer DISUHNM0 2C94 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02364713) MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer. U.S. National Institutes of Health.
3 ClinicalTrials.gov (NCT03171493) Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy. U.S. National Institutes of Health.